Z-VRPR-FMK (TFA) is an irreversible, selective tetrapeptide inhibitor targeting MALT1 protease. It is utilized in biochemical and cellular research to investigate MALT1s role in NF-kappaB signaling, lymphocyte activation, and associated lymphomas through in vitro and in vivo studies.
Molekulargewicht:
790.81
Formel:
C33H50F4N10O8
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
